82 reports

Ovarian Cancer:

  • Ovarian Cancer
  • United States
  • Japan
  • World
  • Cancer Incidence
  • Mortality Rate

Abstract: - Global Ovarian Cancer Therapeutics Market to Reach $6.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Ovarian Cancer Therapeutics estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 18.5% over the analysis...

  • Therapy
  • Ovarian Cancer
  • World
  • China
  • United States

Ovarian Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2020, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur...

  • Ovarian Cancer
  • World

Major players in the ovarian cancer drugs market are AstraZeneca, Roche, Tesaro, Clovis Oncology,and Boehringer Ingelheim. The global ovarian cancer drugs market is expected to grow from $1.49 billion in 2020 to $1.73 billion in 2021 at a compound annual growth rate (CAGR) of 16.1%. The growth is mainly due to the companies rearranging...

  • Ovarian Cancer
  • World
  • Biologics Penetration Rate
  • Cancer Incidence

"Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Epithelial Ovarian Cancer. The marketed products information covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further...

  • Ovarian Cancer
  • World
  • United States
  • Health Expenditure

Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Epithelial Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Ovarian Cancer
  • World

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Ovarian Cancer
  • World

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative...

  • Ovarian Cancer

About this market Ovarian cancer is the second most common gynecologic cancer, and the incidence of the disease has been increasing. The incidence of ovarian cancer increases with age, mainly due to the cell DNA damage associated with age as a result of biological processes or due to the exposure to risk factors. In terms...

  • Ovarian Cancer
  • World

The ongoing clinical trial research report- “2019 Metastatic Ovarian Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Metastatic Ovarian Cancer trials across the world. The report presents top level analysis of global Metastatic Ovarian Cancer clinical trials across countries, companies and universities. It...

  • Ovarian Cancer
  • Clinical Trial
  • World
  • APAC

Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 Summary Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 provides...

  • Ovarian Cancer
  • Cancer
  • World

Abstract: - Global Alpha Emitters Market to Reach $5.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Alpha Emitters estimated at US$672.3 Million in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 34.1% over the analysis period 2020-2027. Melanoma,...

  • Ovarian Cancer
  • Pancreatic Cancer
  • World
  • China
  • United States

Abstract: - Global Women’s Health Diagnostics Market to Reach $48 Billion by 2027 - Amid the COVID-19 crisis, the global market for Women’s Health Diagnostics estimated at US$30.5 Billion in the year 2020, is projected to reach a revised size of US$48 Billion by 2027, growing at a CAGR of 6.7% over the analysis period...

  • Dietary Supplement
  • Diagnostics
  • Ovarian Cancer
  • World
  • China
  • United States

Monoclonal Antibody to Inhibit CD## for Non Small Cell Lung Cancer and Ovarian Cancer - Drug Profile

  • Oncology
  • Monoclonal Antibody
  • Ovarian Cancer
  • Pharmaceutical
  • World

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Metastatic Ovarian Cancer Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Metastatic Ovarian Cancer pipeline products. The Metastatic Ovarian Cancer pipeline guide presents complete overview...

  • Ovarian Cancer
  • World

PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2020-2024 The analyst has been monitoring the parp (Poly ADP-ribose Polymerase) inhibitors market and it is poised to grow by $ 810.23 million during 2020-2024 progressing at a CAGR of 12% during the forecast period. Our reports on parp (Poly ADP-ribose Polymerase) inhibitors...

  • Breast Cancer
  • Ovarian Cancer
  • World

Small Molecules to Inhibit Pan PI##K for Ovarian Cancer – Drug Profile

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

Monoclonal Antibody to Inhibit GRP## for Ovarian Cancer

  • Oncology
  • Ovarian Cancer
  • Biotechnology
  • World
  • Cancer Mortality

Small Molecules to Inhibit Pan PI##K for Ovarian Cancer – Drug Profile

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

Chart ##: Ovarian Cancer Treatment Drugs Sales Volume

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Industrial Production
  • Labour Force

The global clinical trial report- “2019 Metastatic Ovarian Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Metastatic Ovarian Cancer. It presents in-depth analysis of Metastatic Ovarian Cancer clinical trials across markets and companies. The research work is for providing complete understanding...

  • Ovarian Cancer
  • Clinical Trial
  • World

Carcinoembryonic Antigen Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Carcinoembryonic Antigen Market Size, Outlook and Growth Opportunities to 2025: By Application (Colorectal cancer, Pancreatic cancer, Breast cancer, Lung cancer, Ovarian cancer, and Others), By End User (Hospitals, Diagnostic centers,...

  • Healthcare
  • Diagnostics
  • Specialty Hospital
  • Laboratory
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Research Center
  • Pancreatic Cancer
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Community Oncology Services Market Global Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global community oncology services market. This report focuses on community oncology services market which is experiencing strong growth....

  • Clinic
  • Skin Cancer
  • Marketing Research
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Prostate Cancer
  • Renal Cancer
  • Pancreatic Cancer
  • World

Monoclonal Antibody to Inhibit CD## for Non Small Cell Lung Cancer and Ovarian Cancer – Drug Profile

  • Oncology
  • Monoclonal Antibody
  • Ovarian Cancer
  • Pharmaceutical
  • World

Ovarian Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (PARP, PD-L1 Inhibitors , Angiogenesis), By Major Markets (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022 The global ovarian cancer drugs market size is expected to be valued at USD 4.5 billion by 2022 expanding...

  • Ovarian Cancer
  • Targeted Therapy
  • World
  • Europe

Report Scope: This report will provide a detailed overview of ovarian cancer, highlighting treatment guidelines with information on the current and potential global market for ovarian cancer and treatments and testing technologies with detailed analysis of the competitive landscape, including new potential markets for novel...

  • Ovarian Cancer
  • Therapy
  • World

Small Molecules to Inhibit Pan PI##K for Ovarian Cancer – Drug Profile

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • World
  • Pharmaceutical Registrations

Global ovarian cancer gene therapy

  • Ovarian Cancer
  • Gene Therapy
  • United States
  • World
  • Australia
  • Japan
  • Europe
  • Drug Approval
  • Food Production

Ovarian Cancer Diagnostics and Therapeutics Market Report Overview Ovarian Cancer Diagnostics and Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Ovarian Cancer Diagnostics and Therapeutics market types and applications....

  • Therapy
  • Ovarian Cancer
  • World
  • Health Provider Density

Antisense Gene Therapy to Inhibit Telomerase Reverse Transcriptase for Ovarian Cancer – Drug Profile

  • Lung Cancer
  • Antiviral
  • Prostate Cancer
  • Blood Disease
  • Biotechnology
  • Biopharmaceutical
  • Dementia
  • Pharmaceutical
  • Gene Therapy
  • Ovarian Cancer
  • Antisense Technology
  • World
  • Mortality Rate
  • Drug Approval